The Indian Journal of Pediatrics

, Volume 72, Issue 10, pp 859–864 | Cite as

Syndromes and disorders associated with mental retardation

Symposium on Developmental and Behavioral Disorders-I


This article reviews selective comments on the concept of Mental Retardation (MR) in adolescents. Issues covered include the definition, prevalence, and differential diagnosis of MR. Some of the syndromes and disorders associated with MR in the adolescents are also considered with emphasis on the behavioral concerns that may be present in this age group. Finally, concepts of management by the clinician are reviewed. It is recommended that health care professionals caring for adolescents with MR should help these youths maximize their potential as human beings, helping them achieve meaningful functioning in adulthood.

Key words

Mental retardation Cerebral palsy Autism Down syndrome Fragile X syndrome 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Greydanus DE, Bhave S.The Mentally-Challenged Adolescent. Recent Advances in Pediatrics, Kashmir, India, In Press, 2005Google Scholar
  2. 2.
    Wolraich M. “MR” In DE Greydanus and ML Wolraich, eds.Behavioral Pediatrics, NY; Springer-Verlag, 1992; 22: 314–323.Google Scholar
  3. 3.
    American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Text Revision. Washington DC; American Psychiatric Association “MR”, 2000; 41–49.Google Scholar
  4. 4.
    Luckasson R, Coulter D, Polloway EAet al. MR: Definition, Classification, and Systems of Supports, 10th edn. Washington DC; American Association on MR, 2002.Google Scholar
  5. 5.
    Carey JC. Genetic aspects of developmental disabilities In Rudolph, AM Rudolph, eds.Rudolph’s Pediatrics. 21st edn. NY; McGraw Hill Med Pub Div, 2003; 779–782.Google Scholar
  6. 6.
    Leonard H, Wen X. The epidemiology of MR: challenges and opportunities in the new millennium.Ment Retard Dev Disabil Res Rev 2002; 8:117–134.PubMedCrossRefGoogle Scholar
  7. 7.
    Roeleveld N, Zielhuis GA, Gabreëls F. The prevalence of MR. A critical review of recent literature.Dev Med Child Neurol 1997; 39:125–132.PubMedCrossRefGoogle Scholar
  8. 8.
    Shapiro BK, Batshaw ML. “MR”. In RE Behrman, RM Kliegman, HS Junson, eds.Nelson Textbook of Pediatrics, 17th edn. Philadelphia; Saunders, 2004; 138–143.Google Scholar
  9. 9.
    Curry CJ. Rational evaluation of the adolescent with MR.Adolesc Med 2002; 13: 331–343.PubMedGoogle Scholar
  10. 10.
    Lee P, Moss S, Friedlander Ret al. Early-onset schizophrenia in children with MR. diagnostic reliability and stability of clinical features.J Am Acad Child Adolesc Psychiatry 2003; 42:162–169.PubMedCrossRefGoogle Scholar
  11. 11.
    Brier NM. “MR” In SB Friedman, M Fisher, SK Schonberg, eds.Comprehensive Adult Health Care. St. Louis, MO; Quality Med Pub. Inc. 1992; 103: 824–829.Google Scholar
  12. 12.
    Rauh JL. “Mentally Retarded Youth” In McAnarany, RE Kreipe, DP Orr, GD Comeric, eds.Textbook of Adol Med. Phildelphia; WB Saunders Company, 1992; 31:229–232.Google Scholar
  13. 13.
    Wollack JB, Nichter CA. “Cerebral palsy” In CD Rudolph, AM Rudolph, eds.Rudolph’s Pediatrics. 21st edn. NY; McGraw-Hill Medical Publishing Div 2003; 25.5.1: 2197–2202.Google Scholar
  14. 14.
    Toriello HV. Genetics in adolescent medicine. In DE Greydanus, DR Patel, HD Pratt, eds.Essential Adolescent Medicine. NY; McGraw-Hill Medical Publishers, 2005; 21:455–473.Google Scholar
  15. 15.
    Greydanus DE. “Down Syndrone, Williams Syndrome.” In AD Hofmann, DE Greydanus.Adolescent Medicine, 3rd edn. Stanford; CT. Appleton-Lange, 1997; 451.Google Scholar
  16. 16.
    Roizen NJ. Medical care and monitoring for the adolescent with Down Syndrome.Adolesc Med 2002; 13: 345–358.PubMedGoogle Scholar
  17. 17.
    Roizen NJ, Patterson D. Down syndrome.Lancet 2003; 361: 1281.PubMedCrossRefGoogle Scholar
  18. 18.
    Merrick J, Kandel I, Vardi G. Adolescents with Down syndrome.Int J Adolesc Med Health 2004; 16:13–19.PubMedGoogle Scholar
  19. 19.
    Luckstead EF, Cardiovascular Disorders, Essential Adolescent Medicine. DE Greydanus, DR Patel, HD Pratt eds. NY; McGraw-Hill Medical Publishers, 2005; 9: 125–152.Google Scholar
  20. 20.
    Hagerman RJ, Cronister A, eds.Fragile X Syndrome: Diagnosis, Treatment and Research. 2nd edn. Baltimore, MD; Johns Hopkins University Press, 1996.Google Scholar
  21. 21.
    Gutmann DH, Aylsworth A, Carey Jet al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.JAMA 1997; 278:51.PubMedCrossRefGoogle Scholar
  22. 22.
    Dahan D, Fenichel G, El-Said R. Neurocutaneous syndromes.Adol Med 2002; 13:495–509.Google Scholar
  23. 23.
    Goldstone AP. Prader-Willi syndrome: advances in genetics, pathophysiology, and treatment.Trends Endocrinol Metab 2004; 15:12.PubMedCrossRefGoogle Scholar
  24. 24.
    Emanuel BS, McDonald-McGinn D, Saitta SCet al. The 22qll.2 deletion syndrome.Adv Pediatr 2001; 48:39.PubMedGoogle Scholar
  25. 25.
    Lin RJ, Cherry A, Bangs CD, Hoyme HE. FISHing for answers: The use of molecular cytogenetic technizues in adolescent medicine practice.Adol Med 2002; 13: 309–310.Google Scholar
  26. 26.
    Committee on Genetics. American Academy of Pediatrics. Health care supervision for children with Williams Syndrome.Pediatrics 2001; 107:1192–1204.Google Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2005

Authors and Affiliations

  1. 1.Pediatrics and Human DevelopmentMichigan State University College of Human Medicine, Pediatrics Program Director, MSU/Kalamazoo Center for Medical StudiesKalamazooUSA

Personalised recommendations